Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial

Clarke, Edward; (2021) Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Infectious Diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(20)30735-0.

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(20)30735-0.

Abstract

Additional Information

Item Type Article
Faculty and Department MRC Gambia > GM-Vaccinology Theme
Elements ID 155927
Official URL https://www.thelancet.com/journals/laninf/article/...

Share

Download

Published Version Download

Filename: Phase 3 Pneumosil Lancet ID.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar

Google Scholar
Report this Record Edit item (admin only) View this record in elements